Treating hyperpigmentation disorders, such as melasma and Post-Inflammatory Hyperpigmentation (PIH), requires an extremely cautious clinical approach. Melanocytes are highly reactive cellular entities; excessive mechanical trauma, heat, or prolonged intense inflammation can trigger a compensatory hyper-activation, resulting in worsening pigmentation rather than clearance.
To safely deliver skin-lightening actives (such as tranexamic acid or glutathione) to the basal layer without provoking melanocytes, the operational depth must be restricted to 0.25mm–0.50mm, combined with a high motor speed to minimize the mechanical dwell time of the needles inside the skin.
Minimizing pain and thermal/mechanical stress is vital for hyperpigmentation cases. Cartridges engineered with precision-sharpened tips reduce puncture resistance, lowering the nerve-ending stimulation threshold. This low-pain delivery ensures that the treatment remains purely therapeutic, avoiding the localized inflammatory storm that threatens to induce secondary PIH flare-ups.